Snowball today | 雪球

$Shanghai Composite Index(SH000001)$ $GEM Index(SZ399006)$ $ GF Ruiyi Leading Mix(F005233)$ #2022投资摘要# #A股兴奇开门红# #Tesla plummets more than ever, are you panicking if you hold new energy# 2022 is a year when the index will drop sharply. The CSI 300 Index will drop by as much as 21.3%. Such a year provides us with new data for […]

Before summing up, I would like to remind readers as a matter of routine. The opinions and pictures in this article represent only me and have nothing to do with my company. This article does not recommend stocks, does not sell products, and is not a platform for any stocks or funds. It is just

Ten billion top-tier, the current public offering fund industry, is no longer a rarity. Unfortunately, size is always the worst enemy of profitability . In 2022, the tens of billions of top fund managers will eventually lose out to the scale again. In August last year, I was in “Outperforming the China Securities Partial Stock

On December 19, 2021, I published a long article ” Make a 2021 Lost Fund Portfolio “, planning to make a solid fund portfolio from the 10 worst performing mixed funds in 2021, and look forward to some performance in 2022. And on December 28, 2021, they respectively issued the article ” “2021 Lost Fund

The following are the biomedical technology developments that I am looking forward to in 2023: 1. Human clinical data readout of RNAi targeting the lung. 2. Human clinical data readout of RNAi targeting the brain. 3. Further progress in RNAi targeting muscle tissue. 4. Human gene editing inserts genes into human clinical trials for the

On December 31, 2022, Focus announced that it has received financial subsidies. The company will receive a total of 670 million “financial subsidies” in 2022, exceeding 10% of the company’s annual profit. The “financial subsidies” obtained are classified in the following table. In addition to the refund of 20 million personal tax fees and 3

It’s time for the year-end summary, but last year’s heavy position in property stocks and this year’s heavy position in new energy, everyone knows how miserable it is, so I’m really embarrassed to write it, so let’s take stock of Tencent’s data for this year. 1. Stock price and market value As an old chuck,

Huge loss of 72 burgers in 2022 The Borg Z account lost 72.1 burgers in 2022, and the cumulative loss was -14.79%. Regarding the profit target of long-term investment funds, Borg set himself an annualized rate of 15%. At the beginning of 2022, he felt that he could earn 15% that year, but ended up

22 years have passed, and my return is -1.18%. This rate of return is unsatisfactory, but it is stronger than the index. Positions are as shown above   1. Position changes and reasons for this month This month, China Taiping increased its position on the grounds that the idea of ​​real estate becoming a pillar

2022 has experienced the most difficult year for pharmaceutical investment in the past five years. The Fed’s unexpected interest rate hike has compressed liquidity and the equity market. The prevention and control of the epidemic has brought concerns to the economy and the capital market. Most investors have lost confidence in medicine, and the friction

2022 is definitely a small year for the fund, mainly because the fund’s heavy holdings have fallen a lot. But if we start from the beginning of 2018, what is the overall rise and fall of stocks and funds in a full five years? Let’s look at the index first. In the past five years,

Bank of Jiangsu became the champion of last year’s increase, and some people said it was second. It doesn’t matter, the first and second are about the same, in short, it is right that the price rises well. It’s normal that it will cause heated discussions if it rises well. I hold Bank of Jiangsu.

Today is the first day of the new year. I wish you all the best wishes and smooth investment in the new year! There is one of the most basic facts in investment, that is, asset allocation determines more than 90% of investment returns. In other words, the asset class we buy is the core